tradingkey.logo
tradingkey.logo
Search

1 Magnificent ETF I'm Buying Hand Over Fist in 2026

The Motley FoolJul 2, 2026 1:50 PM
facebooktwitterlinkedin
View all comments0

Key Points

  • The Schwab U.S. Dividend Equity ETF holds 100 top high-yielding dividend growth stocks.

  • Dividend growers have historically delivered the highest total returns.

  • The fund also helps further diversify my dividend portfolio.

I typically buy individual stocks. However, I've started investing in more exchange-traded funds (ETFs) over the past year. They help me further diversify my portfolio and sharpen my focus on my highest conviction ideas.

Dividend stocks are one of my highest conviction investments due to their historical outperformance over companies that don't pay dividends. The Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD) does a magnificent job tracking the best ones, which is why I have been buying the ETF hand over fist this year.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

A hand writing out exchange-traded fund.

Image source: Getty Images.

Focused on the best-of-the best

The Schwab U.S. Dividend Equity ETF has a very straightforward investment strategy. It aims to closely track the performance of the Dow Jones U.S. Dividend 100 Index. That index screens companies to find those with higher yields, a consistent record of dividend payments, and relatively strong financial metrics compared to their peers. Among its quality screens are a stock's dividend yield and five-year dividend growth rate. The net result is an index that tracks 100 of the highest-quality, high-yielding dividend stocks.

The index reruns its screen each year and will jettison lower-quality dividend stocks in favor of those with better metrics, ensuring it tracks the top 100 high-yielding dividend stocks. At its last reshuffle, the index booted 22 existing stocks and added 25 new ones. Following the revamp, the index's holdings had an average yield of 3.4% (the same as before and well above the S&P 500's 1.1% yield) and had grown their dividends at a 9.4% annualized rate over the last five years, up from 8.6%.

That dual focus on yield and dividend growth is worth noting. Over the long term, dividend growth stocks have delivered the highest return by dividend policy:

Dividend status

Average annual total return

Dividend Growers & Imitators

10.2%

Dividend Payers

9.2%

Equal-Weight S&P 500 Index

7.7%

No Change in Dividend Policy

6.9%

Dividend Cutters & Eliminators

-1%

Dividend Non-Payers

4.2%

Data source: Ned Davis Research and Hartford Funds.

Unsurprisingly, the Schwab U.S. Dividend Equity ETF's concentrated focus on the best high-yielding dividend growth stocks has yielded strong total returns. Since its inception in 2011, the ETF has delivered an annualized total return of 13.3%.

Further diversifying my dividend investments

The strong returns of dividend growth stocks are why I own several in my portfolio. However, I don't own them all. That's why I also like to hold the Schwab U.S. Dividend Equity ETF, which I see as a good complement to my existing dividend stock portfolio. It helps to further diversify and deepen my holdings.

For example, I only hold four of its 10 largest holdings. Because of that, I'm missing out on some high-quality dividend stocks. Of note, four of its top 10 holdings are healthcare stocks, none of which I currently own. One of those holdings is UnitedHealth Group (NYSE: UNH). The health insurance giant has paid a dividend since 1990 and has increased its payout for the last 16 consecutive years, including a recent 5% increase. It currently yields 2.2%. By investing in SCHD, I'm adding exposure to higher-quality dividend stocks, such as UnitedHealth.

I plan to continue buying this outstanding ETF

I've purchased some shares of the Schwab U.S. Dividend Equity ETF almost every month this year. It delivers above-average income, strong returns, and enhances my diversification. That's why I expect to continue adding to my position this year.

Should you buy stock in Schwab U.S. Dividend Equity ETF right now?

Before you buy stock in Schwab U.S. Dividend Equity ETF, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Schwab U.S. Dividend Equity ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $400,101!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,212,683!*

Now, it’s worth noting Stock Advisor’s total average return is 911% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of July 2, 2026.

Matt DiLallo has positions in Schwab U.S. Dividend Equity ETF. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.